Thomas Aller OD, FBCLA

Thomas Aller, OD, FBCLA, graduated from UC Berkeley School of Optometry and for 28 years he has been researching the use of multifocal contacts for the control of myopia. After receiving the world’s earliest patent for a method of myopia progression control, he spent many years collaborating with BHVI on their anti-myopia program.

Dr. Aller is currently conducting clinical trials in both myopia control and hyperopic reduction with multifocal contact lenses. He has served as a Visiting Scholar at UC Berkeley and an Adjunct Professor at the University of Houston, a member of the International Myopia Institute and was a participant of Essilor’s myopia taskforce. He also serves as a scientific and clinical advisor to many companies engaged in myopia control contacts, spectacles, pharmaceuticals and related instruments. In 2015 he launched Myappia, a myopia progression control progression app. Dr. Aller is the editor of managemyopia.org, a myopia management website for eye care practitioners. 

Dr. Aller received the Award of Excellence from the Global Specialty Lens Symposium, and along with his co-authors, he also received the 2019 Garland Clay Award from the American Academy of Optometry for their paper on their randomized clinical trial of bifocal contact lenses for the control of myopia.